Latest Financial Health News

Nyrada Inc. has secured ethics approval to launch a Phase IIa clinical trial for its heart attack drug Xolatryp®, with patient recruitment set for March 2026. The company maintains a solid cash position of AU$7.12 million as it expands its research into oncology.

InVert Graphite has completed its maiden drilling program at the Kumba deposit in Tanzania, revealing wide zones of high-grade graphite near surface and positioning the Morogoro Project for further advancement.

Pantoro Gold delivered a solid December quarter with strong gold production, robust EBITDA, and promising exploration results at its Norseman Gold Project.

Spheria Emerging Companies Limited announces a fully franked 3.8 cents per share quarterly dividend for December 2025 and initiates monthly dividends of 1.3 cents for February and March 2026 as it transitions dividend payments from quarterly to monthly.

Audeara Ltd reported a strong Q2 FY26 with revenues up 274% year-on-year, securing key regulatory approval in China and expanding its global licensing footprint.

Qoria Limited has reported a record-breaking quarter with annual recurring revenue exceeding US$100 million and a 42% increase in net ARR for Q2 FY2026, reaffirming its strong growth trajectory and FY26 guidance.

Genetic Signatures reported a $3.3 million quarterly revenue with growing international sales and a robust cash position, while preparing for a leadership change.

Rent.com.au has achieved a record quarterly revenue exceeding $1 million, driven by strong recurring income from its RentBond® and RentPay products. This milestone underscores the company’s evolving business model and solid financial footing.

Love Group Global Ltd has reported record operating profits in Q2 FY26, driven by growth in Hong Kong and marketing efficiencies, while planning to expand its matchmaking services into new international markets.

Noble Helium has received a further unsecured loan of AUD 250,000 from its Executive Chair to support working capital, highlighting management’s confidence amid ongoing refinancing efforts.

Global Masters Fund Limited reports steady convertible note activity and a robust loan-to-value ratio of 9.36% for the December 2025 quarter, underscoring its solid financial footing.

Flagship Investments Limited has confirmed stable financial metrics for its convertible notes in the December 2025 quarter, maintaining a conservative loan-to-value ratio and full compliance with regulatory requirements.